BIOMOL
The computed 12-month bankruptcy probability of BIOMOL is 0.2% (very low). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 19 yrs |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-03-2025 | micro | 22-09-2025 | 2025-00500192 |
| 31-03-2024 | micro | 05-10-2024 | 2024-00498323 |
| 31-03-2023 | micro | 11-10-2023 | 2023-00482513 |
| 31-03-2022 | micro | 29-09-2022 | 2022-20445071 |
| 31-03-2021 | micro | 28-10-2021 | 2021-74700536 |
| 31-03-2020 | micro | 22-10-2020 | 2020-63400503 |
| 31-03-2019 | micro | 22-08-2019 | 2019-49600359 |
| 31-03-2018 | micro | 13-08-2018 | 2018-45500453 |
| 31-03-2017 | micro | 28-07-2017 | 2017-39500537 |
| 31-03-2016 | volledig | 29-07-2016 | 2016-38200401 |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 08-03-2007 |
| Status | Active |
| Postal code | 7322 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51522B0014/00G000 | Wallonia | 4,225 m² | 1 · 161 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
10-11-2023 Change in the board of directors
Technical details
{
"events": [],
"notary": {
"name": "Enguerrand de PIERPONT",
"firm_city": null,
"firm_name": null,
"office_city": "Braine-l\u0027Alleud",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-11-10",
"filing_date": "2023-11-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2023-11-07",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0887.780.127",
"name_full": "BIOMOL",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Enguerrand de PIERPONT",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"statuts coordonn\u00E9s au 7 novembre 2023"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | BIOMOL |